comparemela.com
Home
Live Updates
Neurocrine Clinical Sites - Breaking News
Pages:
Latest Breaking News On - Neurocrine clinical sites - Page 1 : comparemela.com
First Patient Dosed in Phase 2 Clinical Trial of NBI-1070770 for MDD
“The selectivity of NBI-1070770 for the NMDA NR2B receptor may benefit patients with moderate to severe depression.”
United states
Long beach
Lemon grove
Eiryw roberts
Neurocrine biosciences inc
Depression rating
Neurocrine clinical sites
Psychiatric times
vimarsana © 2020. All Rights Reserved.